Advanced search
Publication Cover
Expert Opinion on Drug Discovery Volume 18, 2023 - Issue 4
Submit an article Journal homepage
4,031
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Investigating the cell permeability of proteolysis-targeting chimeras (PROTACs)

Hidetomo Yokooa Division of Organic Chemistry, National Institute of Health Sciences, Kawasaki, Japan;b Medical Chemistry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, JapanORCID Iconhttps://orcid.org/0000-0002-9354-6592View further author information
ORCID Icon,
Mikihiko Naitoa Division of Organic Chemistry, National Institute of Health Sciences, Kawasaki, Japan;c Laboratory of Targeted Protein Degradation, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0451-1337View further author information
ORCID Icon &
Yosuke Demizua Division of Organic Chemistry, National Institute of Health Sciences, Kawasaki, Japan;d Graduate School of Medical Life Science, Yokohama City University, Yokohama, Japan;e Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Division of Pharmaceutical Science of Okayama University, Kita, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7521-4861View further author information
ORCID Icon
Pages 357-361 | Received 13 Jan 2023, Accepted 28 Feb 2023, Published online: 12 Mar 2023

References

  • Cecchini C, Tardy S, Scapozza L. Linkers as game-changers in protac technology: emphasizing general trends in PROTAC pharmacokinetics for their rational design. Chimica. 2022;76(4):341–345.
  • Lipinski CA, Lombardo F, Dominy BW, et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001;46(1–3):3–26.
  • Veber DF, Johnson SR, Cheng HY, et al. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem. 2002;45(12):2615–2623.
  • Klein VG, Bond AG, Craigon C, et al. Amide-to-ester substitution as a strategy for optimizing PROTAC permeability and cellular activity. J Med Chem. 2021;64(24):18082–18101.
  • Kerns EH, Di L, Carter GT. In vitro solubility assays in drug discovery. Curr Drug Metab. 2008;9(9):879–885.
  • Jimenez DG, Sebastiano MR, Caron G, et al. Are we ready to design oral PROTACs®? ADMET DMPK. 2021;9(4):243–254.
  • Scott DE, Rooney TPC, Bayle ED, et al. Systematic investigation of the permeability of androgen receptor PROTACs. ACS Med Chem Lett. 2020;11(8):1539–1547.
  • Galdeano C, Gadd MS, Soares P, et al. Structure-guided design and optimization of small molecules targeting the protein-protein interaction between the von Hippel–Lindau (VHL) E3 ubiquitin ligase and the Hypoxia Inducible Factor (HIF) alpha subunit with in vitro nanomolar affinities. J Med Chem. 2014;57(20):8657–8663.
  • Lv D, Pal P, Liu X, et al. Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity. Nat Commun. 2021;12(1):6896.
  • Maple HJ, Clayden N, Baron A, et al. Developing degraders: principles and perspectives on design and chemical space. MedChemComm. 2019;10(10):1755–1764.
  • Yokoo H, Shibata N, Endo A, et al. Discovery of a highly potent and selective degrader targeting hematopoietic prostaglandin D synthase via in silico design. J Med Chem. 2021;64(21):15868–15882.
  • Poongavanam V, Atilaw Y, Siegel S, et al. Linker-dependent folding rationalizes PROTAC cell permeability. J Med Chem. 2022;65(19):13029–13040.
  • Lebraud H, Wright DJ, Johnson CN, et al. Protein degradation by in-cell self-assembly of proteolysis targeting chimeras. ACS Cent Sci. 2016;2(12):927–934.
  • Wei M, Zhao R, Cao Y, et al. First orally bioavailable prodrug of proteolysis targeting chimera (PROTAC) degrades cyclin-dependent kinases 2/4/6 in vivo. Eur J Med Chem. 2021;209:112903.
  • Liu J, Chen H, Liu Y, et al. Cancer selective target degradation by folate-caged PROTACs. J Am Chem Soc. 2021;143(19):7380–7387.
  • Dragovich PS, Pillow TH, Blake RA, et al. Antibody-mediated delivery of chimeric BRD4 degraders. part 1: exploration of antibody linker, payload loading, and payload molecular properties. J Med Chem. 2021;64(5):2534–2575.
  • He S, Gao F, Ma J, et al. Aptamer-PROTAC conjugates (APCS) for tumor-specific targeting in breast cancer. Angew Chem Int Ed. 2021;60(43):23299–23305.
  • Sakamoto KM, Kim KB, Kumagai A, et al. Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation. Proc Natl Acad Sci USA. 2001;98(15):8554–8559.
  • Yokoo H, Ohoka N, Takyo M, et al. Peptide stapling improves the sustainability of a peptide-based chimeric molecule that induces targeted protein degradation. Int J Mol Sci. 2021;22(16):8772.
  • Chen Y, Tandon I, Heelan W, et al. Proteolysis-targeting chimera (PROTAC) delivery system: advancing protein degraders towards clinical translation. Chem Soc Rev. 2022;51(13):5330–5350.
  • Zhang C, Zeng Z, Cui D, et al. Semiconducting polymer nano-PROTACs for activatable photo-immunometabolic cancer therapy. Nat Commun. 2021;12(1):2934.
  • Pike A, Williamson B, Harlfinger S, et al. Optimising proteolysis-targeting chimeras (PROTACs) for oral drug delivery: a drug metabolism and pharmacokinetics perspective. Drug Discov Today. 2020;25(10):1793–1800.
  • Hendrick CE, Jorgensen JR, Chaudhry C, et al. Direct-to-biology accelerates PROTAC synthesis and the evaluation of linker effects on permeability and degradation. ACS Med Chem Lett. 2022;13(7):1182–1190.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.